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Prevalence of potentially inappropriate prescribing in older  
people in primary care and its association with hospital  
admission: longitudinal study
Teresa Pérez,1,2 Frank Moriarty,2 Emma Wallace,2 Ronald McDowell,2,3 Patrick Redmond,2,4  
Tom Fahey2
ABSTRACT
OBJECTIVE
To determine whether hospital admission is 
associated with potentially inappropriate prescribing 
among older primary care patients (aged ≥65 years) 
and whether such prescribing was more likely after 
hospital admission than before.
DESIGN
Longitudinal study of retrospectively extracted data 
from general practice records.
SETTING
44 general practices in Ireland in 2012-15.
PARTICIPANTS
Adults aged 65 years or over attending participating 
practices.
EXPOSURE
Admission to hospital (any hospital admission versus 
none, and post-admission versus pre-admission).
MAIN OUTCOME MEASURES
Prevalence of potentially inappropriate prescribing 
assessed using 45 criteria from the Screening Tool 
for Older Persons’ Prescription (STOPP) version 
2, analysed both as rate of distinct potentially 
inappropriate prescribing criteria met (stratified 
Cox regression) and binary presence of potentially 
inappropriate prescribing (logistic regression) and 
adjusted for patients’ characteristics. A sensitivity 
analysis used matching with propensity scores based 
on patients’ characteristics and diagnoses.
RESULTS
Overall 38 229 patients were included, and during 
2012 the mean age was 76.8 (SD 8.2) years and 
43% (13 212) were male. Each year, 10.4-15.0% 
(3015/29 077 in 2015 to 4537/30 231 in 2014) 
of patients had at least one hospital admission. 
The overall prevalence of potentially inappropriate 
prescribing ranged from 45.3% (13 940/30 789) of 
patients in 2012 to 51.0% (14 823/29 077) in 2015. 
Independently of age, sex, number of prescription 
items, comorbidity, and health cover, hospital 
admission was associated with a higher rate of 
distinct potentially inappropriate prescribing criteria 
met; the adjusted hazard ratio for hospital admission 
was 1.24 (95% confidence interval 1.20 to 1.28). 
Among participants who were admitted to hospital, 
the likelihood of potentially inappropriate prescribing 
after admission was higher than before admission, 
independent of patients’ characteristics; the adjusted 
odds ratio for after hospital admission was 1.72 
(1.63 to 1.84). Analysis of propensity score matched 
pairs showed a slight reduction in the hazard ratio for 
hospital admission to 1.22 (1.18 to 1.25).
CONCLUSION
Hospital admission was independently associated 
with potentially inappropriate prescribing. It is 
important to determine how hospital admission 
may affect appropriateness of prescribing for older 
people and how potential adverse consequences of 
admission can be minimised.
Introduction
Adults aged 65 years and over are a growing 
population and represent the largest consumers of 
prescribed drugs.1 2 Although optimal prescribing aims 
to maximise benefits to patients while minimising 
harms and costs, achieving this balance when 
caring for older patients in primary care can be 
challenging. Physiological changes in ageing can 
impair metabolism and excretion of drugs and increase 
sensitivity to their effects.3 In addition, older patients 
tend to have a higher burden of multimorbidity and 
so take more drugs, contributing to both increased 
treatment burden and potential drug-drug and 
drug-disease interactions.4 Lastly, although most 
prescribing in primary care is repeat prescribing,5 such 
drugs are often initially prescribed in secondary care, 
which can be problematic as the general practitioner 
is responsible for coordination and managing all 
prescriptions.6 This can be even more challenging 
for patients with multimorbidity who attend multiple 
healthcare providers.
Use of prescribed drugs among older adults is 
increasing despite the high risk of adverse drug events 
and resultant morbidity and mortality.1 2 7 A recent 
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systematic review focusing on adverse drug events in 
ambulatory care found prevalence rates ranging from 
2.8% to 34.7%, up to a quarter of which were judged 
to be preventable.8 Another systematic review reported 
that 9.9% of all hospital admissions in people aged 65 
years or over were as a result of an adverse drug event.9
Appropriateness of prescribing can be assessed 
by process measures (that is, what providers do) or 
outcome measures (that is, patient outcomes). These 
measures can be either implicit (judgment based) or, 
more often, explicit (criterion based).10 Examples 
of explicit measures include the Beers criteria and 
the Screening Tool of Older Person’s potentially 
inappropriate Prescribing (STOPP) and Screening 
Tool to Alert doctors to the Right Treatment (START).11 
Explicit measures have the advantage of being based 
on literature review and expert consensus, and they 
are reliable and have content validity, although they 
do periodically need revision to reflect new evidence. 
In 2015 the STOPP/START criteria were updated to add 
new criteria and remove obsolete ones.11 In STOPP/
START 2, the final list of 114 criteria, including 80 
STOPP criteria and 34 START criteria, was agreed 
after two rounds of Delphi validation.11 The STOPP/
START 2 criteria can be used to examine potentially 
inappropriate prescribing in older people.
The adverse outcomes associated with the STOPP 
criteria are well established, including adverse 
drug events, emergency admissions or emergency 
department visits, and poorer quality of life.12-15 
Previous studies have examined predictors of 
potentially inappropriate prescribing, such as patients’ 
characteristics (for example, multimorbidity, age, 
and number of prescribed drugs), and characteristics 
of general practices (for example, deprivation of 
catchment area).16 17 There has been less focus on how 
health system factors, such as hospital admission or 
care transitions, may contribute to the appropriateness 
of prescribing for ambulatory care patients.
Therefore, the objectives of this study were to use 
the revised STOPP criteria to estimate the annual 
prevalence of potentially inappropriate prescribing 
in older community dwelling people in Ireland, to 
examine any association between hospital admission 
and potentially inappropriate prescribing, and to 
compare the prevalence of potentially inappropriate 
prescribing before and after hospital admission. 
We hypothesised that occurrence of potentially 
inappropriate prescribing among older adults may 
be significantly associated with hospital admission 
and, among patients who were admitted to hospital, 
occurrence of potentially inappropriate prescribing 
may differ before and after admission.
Methods
Study population and study design
This was a longitudinal study using a retrospectively 
collected dataset that included general practitioners’ 
patients aged 65 years or over between 2012 and 
2015. We used the patient management system 
Socrates (www.socrates.ie) to collect data from 44 
general practices in Ireland, including prescribing, 
demographic, clinical, and hospital admission 
records. Socrates is one of four electronic health 
record vendor systems accredited by the Irish College 
of General Practitioners. Most (94%) general practices 
in Ireland are computerised, and electronic morbidity 
coding and prescribing occurs in more than 90% of 
these computerised practices.18 Although the validity 
of morbidity recording in Ireland is not as good as 
in the UK, recent initiatives have improved both 
completeness and validity of morbidity coding.19 
Socrates has created quality indicator tools used for 
audit and also in research, such as a study of resistance 
patterns of urinary tract infections.20 The STROBE 
(STrengthening the Reporting of OBservational studies 
in Epidemiology) statement was used in the conduct 
and reporting of this study.21
Explanatory variables and outcomes of interest
We identified potentially inappropriate prescribing, 
according to 45 STOPP 2 criteria, by using information 
on drugs and diagnoses for each patient in the dataset, 
in each of the four years. A total of 35 (44%) criteria 
could not be applied—for example, owing to lack 
of information on laboratory monitoring, history 
of falls, or prescribing indication (see appendix 1). 
Where necessary, we included prescribing and 
diagnosis information from before 2012 when 
estimating the prevalence of potentially inappropriate 
prescribing—for example, for criteria relating to first 
line treatment. An extensive description of criteria and 
their application is provided in appendix 2. For each 
patient, we calculated the total number and dates of 
first occurrence of distinct potentially inappropriate 
prescribing criteria met per calendar year. We analysed 
these either as recurrent events (that is, rate of distinct 
potentially inappropriate prescribing criteria met 
per year) or as a dichotomous variable (at least one 
potentially inappropriate prescription in the period 
considered or no event).
The STOPP criteria, as explicit measures of 
inappropriate prescribing, have been used extensively 
in research as measures of the process of care. Their 
validity has been established in multiple studies 
showing their relation with important outcomes 
for patients. In terms of predictive validity, STOPP 
modestly discriminates for outcomes such as 
adverse drug events, emergency department visits, 
and hospital admissions (C indices of 0.65-0.70).22 
Other observational studies have found consistent 
associations between the STOPP criteria and avoidable 
adverse drug events relevant to the index admission 
among hospital inpatients,12 poorer quality of life,14 
emergency department visits,14 15 and unplanned 
readmission to hospital.23 Prescribing included in 
STOPP was considered causal in 30% of adverse drug 
reactions in a Swedish study in an older population,24 
and in a study of definitely or possibly avoidable 
adverse drug events that led to hospital admission, 
62.2% were listed in the STOPP criteria.12 On this basis, 
the STOPP criteria can be considered a valid process 
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measure of quality of care, and they have been used 
as primary outcomes in interventional trials aiming to 
improve prescribing.25 26
To examine the association between hospital 
admission and potentially inappropriate prescribing, 
we defined the explanatory variable hospital admission 
as a dichotomous variable (no hospital admission 
versus any admission). Hospital admission was 
incorporated as a time dependent variable in the Cox 
model, considered as “no hospital admission” before 
the date of the first admission and “hospital admission” 
after that date. All practices included elective and 
emergency admissions to public hospitals, and four 
of the 44 practices additionally included emergency 
department attendances. For the comparison of 
potentially inappropriate prescribing before and after 
hospital admission, the explanatory variable was time 
period (after hospital admission versus before). The 
post-admission period started on the day after hospital 
admission. For those patients admitted more than 
once in the same year, we considered only the first 
admission.
Categorical covariates adjusted for in all models 
were sex and type of health cover (with four categories: 
General Medical Services (GMS) scheme, Doctor Visit 
Card (DVC), private patient, and other). Continuous 
covariates were age (years), number of prescription 
items in that period, and multimorbidity. The GMS 
and DVC schemes are types of public health coverage, 
providing eligible patients with a range of health 
services including general practitioner visits free of 
charge. These are means tested, with eligibility based 
on household income and age. The GMS scheme 
covers the most socioeconomically deprived people, 
approximately one third of the population, and 90% 
of those aged 70 years or over, for whom a lower 
income threshold applies.27 The DVC scheme covers 
people with higher, but still limited, means. Other 
people pay out-of-pocket for primary care services 
such as general practitioner visits and drugs; hence 
Ireland has a mixed public-private healthcare system. 
We assessed the number of prescription items as 
the total number of items prescribed to a patient per 
year, not accounting for multiple issues/repeats on 
prescriptions. We assessed multimorbidity by using 
the Charlson comorbidity index.28 This index is based 
on 17 conditions weighted by one year mortality risk, 
and a higher score indicates more severe comorbidity.
Statistical analyses
Annual prevalence of potentially inappropriate 
prescribing
We described demographic and clinical characteristics 
of patients (such as age, sex, health cover type, 
number of prescription items, and multimorbidity) 
and the overall prevalence of potentially inappropriate 
prescribing for each year considered. Data are 
expressed as mean (standard deviation), median 
(interquartile range), and proportions (absolute and 
relative frequencies) as appropriate. Analyses were run 
on a complete case basis, and the numbers of people 
included in each analysis are reported in the relevant 
tables and figures.
Association between potentially inappropriate 
prescribing and hospital admission
We examined the relation between potentially 
inappropriate prescribing and hospital admission 
adjusted for age, sex, health cover type, number of 
prescription items, and multimorbidity. We fitted both 
a mixed effect logistic regression model (in which 
the outcome was defined as dichotomous (0 without 
any potentially inappropriate prescribing in that 
year, or 1 otherwise)) and the Prentice, Williams, and 
Peterson (PWP) model (in which the outcome was time 
from the beginning of the year to a new potentially 
inappropriate prescribing criterion observed in each 
patient per calendar year). The mixed effect logistic 
regression model extends the general linear model 
by incorporating correlations among the outcomes 
(multiple observations per patient). This can be 
accomplished by including random effects. In this 
study, we introduced two random effects representing 
the patient and the year. We used the MCMCglmm 
package in R,29 30 because models obtained using 
the glmer function of the lme4 package did not 
converge. Modelling of the rate of distinct potentially 
inappropriate prescribing events used the PWP 
model,31 which is an extension of the Cox proportional 
hazard model. We used a stratum variable to keep track 
of the number of previous potentially inappropriate 
prescribing criteria met, allowing the hazard for a 
new potentially inappropriate prescribing criterion 
to change after a previous event. We used a robust 
variance estimator to account for individual patients’ 
heterogeneity.32 We included hospital admission as a 
time dependent variable that could change from “no 
hospital admission” to “hospital admission” during 
each year. We did a stratified analysis for health cover 
type because the proportional hazard assumption was 
not satisfied. We obtained an overall hazard ratio for 
the whole study period, also stratifying by year. As the 
date of death was not included in the dataset, within 
each year the length of follow-up was until the end 
of the year if the patient had a record in the following 
year or up until the date of the last prescription in 
that year if not. We used the survival package in R for 
this analysis.33 To avoid double counting, we omitted 
criterion 32 from this analysis because it overlapped 
fully with criterion 1 (both relate to long term use of 
non-steroidal anti-inflammatory drugs; see appendix 2 
for further details).
Potentially inappropriate prescribing before and 
after admission to hospital
We did a second analysis comparing potentially 
inappropriate prescribing before and after hospital 
admission among only those patients who were 
admitted to hospital during a study year. Paired 
sample tests (that is, having two observations per 
patient: one for presence/absence of potentially 
inappropriate prescribing before hospital admission 
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and one for after admission) allowed the temporality 
of the relation between hospital admission and 
potentially inappropriate prescribing to be assessed 
and also accounted for between patient variability. 
We fitted a mixed effect logistic regression model 
and included a random intercept for each patient to 
allow between patient variability in the outcome and 
for each year, using the MCMCglmm package in R.30 
The outcome was whether or not the patient had any 
potentially inappropriate prescribing event in the time 
period considered. The explanatory variable was time 
period (after hospital admission, relative to before 
admission), with adjustments made for the covariates 
listed above. In all analyses, we defined P<0.05 as 
statistically significant.
Sensitivity analyses
Firstly, we repeated each of the above analyses 
separately by calendar year to assess the consistency 
of observed associations over the study period. 
Secondly, owing to some missing data for the Charlson 
comorbidity index, we also repeated analyses using 
an alternative measure of multimorbidity. We used 
RxRisk-V, a prescription based measure of morbidity 
including medication proxies for 45 conditions, which 
has shown criterion validity and reliability compared 
with patients’ medical diagnoses.34 Prescription 
data were available for all included participants, and 
RxRisk was adjusted for in models as a binary indicator 
of multimorbidity (that is, two or more conditions).
Lastly, as patients were not randomly allocated to 
being admitted to hospital or not, these groups may 
have differences in their characteristics that could 
bias estimates. We did a sensitivity analysis using 
propensity score matching to assess whether the 
association between hospital admission and potentially 
inappropriate prescribing could be due to unmeasured 
confounders.35 We used the propensity score, defined 
as the conditional probability of hospital admission 
given the measured covariates, to balance covariates 
in the two groups. Using the MatchIt package in R,36 
we first fitted a logistic regression model to estimate 
propensity scores. We modelled the conditional 
probability of hospital admission as a function of 
baseline and those clinical characteristics associated 
with admission that were also independent risk 
factors for potentially inappropriate prescribing. These 
variables included age, sex, health cover type, number 
of prescription items, Charlson comorbidity index, and 
whether the patient had been diagnosed as having any 
of the five most common conditions (diabetes, chronic 
obstructive pulmonary disease, any type of tumour, 
a myocardial infraction, or cerebrovascular disease). 
We randomly selected each patient with a hospital 
admission and then matched them with the patient 
with no admission with the closest propensity score. 
Finally, we fitted the same models considering only the 
matched pairs.
Patient involvement
Patients were not involved in the conception, design, 
or conduct of this research. We plan to disseminate 
the findings to the public and patients through our 
contacts in patient representative bodies, the popular 
media, and the participating general practices.
Results
Descriptive statistics
A total of 38 229 patients were included in the 
dataset over the period 2012 to 2015. Table 1 shows 
demographics and clinical characteristics of this 
sample, by year. We excluded patients without 
prescriptions during the period analysed. During 2012, 
the mean age of included patients was 76.8 (SD 8.2) 
years and 43% were male. For each study year, 10.4-
15.0% of patients had at least one hospital admission.
Annual prevalence of potentially inappropriate 
prescribing
The overall prevalence of potentially inappropriate 
prescribing ranged from 45.3% (13 940/30 789) of 
patients in 2012 to 51.0% (14 823/29 077) in 2015 
(appendix 3). The individual criteria with the highest 
prevalence in 2015 included proton pump inhibitor for 
uncomplicated peptic ulcer disease or erosive peptic 
oesophagitis at full therapeutic dosage for more than 
eight weeks (7836; 26.9%), benzodiazepines for at 
least four weeks (5562; 19.1%), and drugs prescribed 
beyond the recommended duration (3988; 13.7%, 
primarily driven by Z drug hypnotics (zolpidem, and 
Table 1 | Demographics and main clinical characteristics by year. Values are numbers (percentages) unless stated otherwise
Demographic and clinical characteristics 2012 (n=30 753) 2013 (n=30 789) 2014 (n=30 231) 2015 (n=29 077) Missing data (%)
Mean (SD) age, years 76.8 (8.2) 76.4 (8.1) 75.9 (7.8) 75.0 (7.6) 0.08
Male sex 13 212 (43.0) 13 335 (43.3) 13 176 (43.6) 12 687 (43.6) 0.08
Patients with hospital admission 4151 (13.5) 4496 (14.6) 4537 (15.0) 3015 (10.4) 0
Health cover:
0.03
 General Medical Services scheme 21 053 (68.5) 21 472 (69.7) 21 202 (70.1) 20 859 (71.7)
 Doctor Visit Card 3029 (9.8) 3153 (10.2) 3201 (10.6) 3280 (11.3)
 Private patients 6518 (21.2) 6004 (19.5) 5705 (18.9) 4817 (16.6)
 Other 153 (0.5) 160 (0.5) 123 (0.4) 71 (0.2)
Median (interquartile range) prescription items per patient 22 (9-42) 22 (9-43) 23 (10-44) 21 (9-40) 0
Mean (SD) Charlson comorbidity index 0.89 (1.23) 0.94 (1.27) 1 (1.31) 1 (1.31) 24.2
Prevalence of potentially inappropriate prescribing events:
0 1 6452 (21.0) 6843 (22.2) 6771 (22.4) 6857 (23.6) 2 4171 (13.6) 4254 (13.8) 4429 (14.6) 4220 (14.5)
 ≥3 3317 (10.8) 3654 (11.9) 3762 (12.4) 3746 (12.9)
copyright.
 o
n
 11 Septem
ber 2019 at G
uy's & St Thom
as' Hospitals NHS Trust. Protected by
http://www.bmj.com/
BM
J: first published as 10.1136/bmj.k4524 on 14 November 2018. Downloaded from 
RESEARCH
the bmj | BMJ 2018;363:k4524 | doi: 10.1136/bmj.k4524 5
zopiclone) for more than four weeks), and this was 
observed in each calendar year (appendix 3).
Association between potentially inappropriate 
prescribing and hospital admission
In the PWP regression model, hospital admission, 
higher age, greater number of prescription items, and 
multimorbidity were all associated with a higher rate 
of potentially inappropriate prescribing events. The 
rate of distinct criteria met per year increased by 24% 
if a patient had been admitted to hospital (hazard 
ratio 1.24, 95% confidence interval 1.20 to 1.28) 
when controlled for the other covariates (fig 1). For 
sex, the rate of potentially inappropriate prescribing 
criteria met per year was approximately 12% lower 
for men (hazard ratio 0.88, 0.87 to 0.89). The rate of 
distinct potentially inappropriate prescribing criteria 
observed in one year also increased as age, number of 
prescription items, and multimorbidity increased.
Results obtained from the mixed effect logistic 
regression model were analogous, although in this 
model age was not significant (see appendix 4). The 
odds ratio for hospital admission was 1.49 (1.42 to 
1.58)—that is, the probability of at least one potentially 
inappropriate prescription during a year increased by 
49% for patients admitted to hospital, after adjustment 
for relevant covariates.
Potentially inappropriate prescribing before and 
after admission to hospital
Having analysed potentially inappropriate prescribing 
in patients who were admitted to hospital compared 
with those who were not, we determined the effect 
of admission on a patient’s likelihood of having 
potentially inappropriate prescribing among only 
those patients who were admitted. Figure 2 shows the 
estimated odds ratios with 95% credible intervals. 
Among patients who had at least one hospital 
admission in a year, the risk of having any potentially 
inappropriate prescription increased by 72% after 
admission to hospital. Women and patients with 
greater numbers of prescription items were more likely 
to have potentially inappropriate prescriptions.
Sensitivity analysis
When analyses were repeated on a year by year 
basis, the relation between hospital admission and 
potentially inappropriate prescribing was consistent 
over time (appendix 5). Adjustment for multimorbidity 
using RxRisk instead of the Charlson comorbidity 
index (table 2), and therefore inclusion of participants 
for whom diagnostic coding may have been missing, 
resulted in little change in the magnitude of the 
parameter estimates for hospital admission. Lastly, 
propensity score matching compared patients 
admitted to hospital with those who were not 
admitted, using both the PWP model (fig 3) and the 
logistic model (appendix 6). These analyses still 
showed a statistically significant association between 
hospital admission and the outcome of potentially 
inappropriate prescribing (adjusted hazard ratio 1.22, 
1.18 to 1.25; adjusted odds ratio 1.48, 1.37 to 1.58).
Discussion
This study found that a substantial proportion 
of community dwelling older people had at least 
one potentially inappropriate prescription defined 
according to the STOPP 2 criteria and that hospital 
admission was a significant marker of potentially 
inappropriate prescribing. Set against a general increase 
in potentially inappropriate prescribing and patients 
with multiple potentially inappropriate prescribing 
criteria met, we determined that after control for the 
characteristics assessed in this study (such as age, 
number of prescriptions, and multimorbidity) hospital 
admission was associated with a higher rate of 
potentially inappropriate prescribing. Furthermore, for 
patients who were admitted to hospital, their likelihood 
of having potentially inappropriate prescribing 
increased by 72% after admission compared with 
before, independent of other patient related factors. 
These relations were consistent across study years 
and were robust to different analytical approaches in 
sensitivity analyses.
Strengths and weaknesses of study
This study included a large sample of community 
dwelling older adults and used the most recent 
version of the STOPP criteria to assess potentially 
inappropriate prescribing. Using two different 
approaches (unpaired and paired samples), we 
obtained consistent conclusions. However, owing 
to the secondary nature of this analysis, 35 (44%) 
of 80 STOPP criteria for which relevant patient 
information was unavailable could not be applied 
(see appendix 1). Like other explicit measures of 
potentially inappropriate prescribing, STOPP does 
not account for clinical judgment and individual 
clinical circumstances in which prescribing may 
be justified and appropriate in certain patients. 
However, STOPP has consistently been associated 
with poorer patient outcomes.13 The quality of 
clinical coding of diagnoses was somewhat variable, 
which precluded application of the START criteria 
to identify prescribing omissions. This may be of 
  Admitted to hospital
  Age
  Male sex
  No of prescriptions
  Multimorbidity
1.24 (1.20 to 1.28)
1.01 (1.01 to 1.01)
0.88 (0.87 to 0.89)
1.01 (1.01 to 1.01)
1.04 (1.03 to 1.04)
0 0.5 1.5 2.01.0
Prentice, Williams,
and Peterson model
Hazard ratio
(95% CI)
Hazard ratio
(95% CI)
Fig 1 | Estimated hazard ratios (95% CI) for rate of distinct potentially inappropriate 
prescribing criteria met among all participants. Reference groups were no hospital 
admission and female sex
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particular interest for future research assessing the 
effect of hospital admission on appropriateness of 
prescribing, as unintentional omission of treatments 
is noted as the most common medication error at 
transitions of care.37
We addressed the quality of clinical and diagnostic 
coding by doing a sensitivity analysis using a 
prescription based measure of multimorbidity for 
adjustment and showed little effect on the results. 
Although general practices were recruited from a wide 
geographical area, they may not be representative of 
all practices, with the potential for volunteer bias. 
However, the analysis included patients with any 
type of health cover, compared with other studies 
limited to participants eligible for the means tested 
GMS scheme. Variability in coding for hospital 
admission existed between practices, and private 
hospital admissions were not captured, leading to 
potential for misclassification of exposure status for 
patients. However, the vast majority of secondary care 
interactions for older patients would be with public 
hospitals, so this is unlikely to significantly affect the 
findings. A high percentage of patients had complete 
follow-up over the course of the study. We did not have 
access to reasons for loss to follow-up, which could 
include mortality, moving practice, or admission to 
care homes (residential or nursing). However, results 
were robust to the possibility of dependent censoring. 
Although we adjusted for a range of characteristics 
of patients, as with any observational study potential 
exists for unmeasured confounding, which may 
partly or fully explain the relation between hospital 
admission and potentially inappropriate prescribing. 
We assessed the robustness of our result to different 
adjustment methods by using a propensity matched 
sensitivity analysis, but residual confounding due to 
other factors, such as the severity of illness, may still 
exist.
Comparison with previous studies
The literature examining the effect of hospital 
admission on potentially inappropriate prescribing 
is limited. Some studies have compared medication 
appropriateness at hospital admission and discharge, 
including potentially inappropriate prescribing 
defined by Beers criteria alone or in addition to STOPP/
START.38-40 In these studies, either no difference 
or a small reduction in potentially inappropriate 
prescribing was found between admission and 
discharge.38-40 However, only the relatively short 
period of hospital admission was considered and the 
effect on primary care prescribing after discharge 
was not assessed. These studies included between 
approximately 180 and 2000 patients; in contrast to 
our study of more than 40 000 people, they may have 
been underpowered to detect an association.
A previous study assessed the prevalence of 
potentially inappropriate prescribing among 1016 
older GMS scheme patients in Ireland presenting at 
one emergency department after a fall.41 The overall 
prevalence of both the STOPP criteria (version 1) 
and Beers criteria (2012) did not change in the 12 
months after the fall compared with before the fall. 
Prescribing of some drugs associated with falls, such 
as neuroleptics and benzodiazepines, did decrease, 
however. Discordance between these findings and ours 
may be because these patients were attending hospital 
for a specific adverse event (a fall), so an assessment of 
risk factors contributing to this, including drugs, was 
likely done during or after discharge from hospital.
In our study, we applied the recently revised 2015 
STOPP 2 criteria—that is, the most current definition of 
potentially inappropriate prescribing. The prevalence 
here is closely comparable to estimates from other 
studies using STOPP 2, which ranged from 40.4% and 
56% among community dwelling people aged at least 
65 and 80 years, respectively,42 43 to between 41.5% 
and 71.5% in older patients being discharged from 
hospital.39 44 As in our study, long term prescription 
of benzodiazepines and Z drugs was common in 
several other studies using STOPP 2.39 42-45 In contrast, 
the long term use of proton pump inhibitors, the 
most common criterion in our study, was noted as 
particularly prevalent in only two previous studies 
using STOPP 2.39 45
  Aer hospital admission
  Age
  Male sex
  No of prescriptions
  Multimorbidity
1.72 (1.63 to 1.84)
1.00 (1.00 to 1.01)
0.81 (0.76 to 0.85)
1.03 (1.03 to 1.03)
1.01 (0.98 to 1.02)
0 0.5 1.5 2.01.0
Logistic model Odds ratio
(95% CI)
Odds ratio
(95% CI)
Fig 2 | Estimated odds ratios (with 95% credible intervals) for presence of potentially 
inappropriate prescribing among only participants admitted to hospital. Reference 
groups were before hospital admission and female sex. Also adjusted for patient health 
cover type, which did not show any significant association
  Hospital admission
  Age
  Male sex
  No of prescriptions
  Multimorbidity
1.22 (1.19 to 1.26)
1.01 (1.00 to 1.01)
0.87 (0.85 to 0.89)
1.01 (1.01 to 1.01)
1.03 (1.02 to 1.04)
0 0.5 1.5 2.01.0
Prentice, Williams,
and Peterson model
Hazard ratio
(95% CI)
Hazard ratio
(95% CI)
Fig 3 | Estimated hazard ratios (95% CI) for rate of distinct potentially inappropriate 
prescribing events among propensity score matched participants. Reference groups 
were no hospital admission and female sex
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Implications for clinicians, research, and policy
Inpatient admissions can provide the opportunity for 
specialist teams to review and optimise management 
of older patients’ chronic conditions, including their 
drugs.46 Although hospital admissions have the 
potential to improve management of drugs, this study 
suggests these possible benefits to appropriateness of 
prescribing after discharge to primary care are not being 
realised. Our findings suggest that hospital admission 
(which may result from a change in a patient’s clinical 
status and may result in an intensification of healthcare) 
is an important driver of potentially inappropriate 
prescribing and the overuse and/or misuse of drugs. 
Medicines management services for inpatients in 
Ireland are broadly similar to those in the UK; however, 
the extent to which they are provided in practice is 
variable owing to resourcing of hospital pharmacy 
services. In approximately 40% of Irish hospitals, 
pharmacists do admission medication reconciliation 
and review, which is similar to the proportion in UK 
hospitals, although fewer Irish hospitals involve 
pharmacists in emergency department and acute 
medical assessment units.47 Most provide inpatient 
clinical pharmacy services; however, unlike the UK, in 
most (86%) Irish hospitals pharmacists had no formal 
involvement in the discharge prescribing process. 
The vast majority also do not supply drugs to patients 
on discharge, and about half provide pharmacist 
counselling on discharge drugs.47 The 2017 National 
Patient Experience Survey report underlines the need 
for improved medication management services at 
discharge, where 40% of patients reported not being 
advised about drug side effects to be aware of.48
Poor coordination of transitions between care 
settings (from secondary to primary care), can put 
patients at increased risk of medication errors, 
adverse drug events, and readmissions.49-51 Improving 
coordination of care, particularly for older patients 
with complex care needs, has been identified as an 
international policy priority.52 53 Transitional care 
interventions for older patients with chronic disease 
discharged from hospital to primary care have been 
evaluated in a recent systematic review.54 Evidence 
suggests that these interventions can reduce mortality, 
hospital readmissions, and number of readmission 
days after 3-18 months (for example, a mortality risk 
difference at 18 months of −0.07 (95% confidence 
interval −0.12 to −0.02)), but no evidence of a benefit 
to quality of life was shown in meta-analysis.54 A 
recent quasi-experimental study evaluated the effect 
of a medication management system (Pharm2Pharm) 
provided by hospital and community pharmacists 
for older adults at risk of medication problems.55 The 
intervention seemed to reduce the drug related hospital 
admission rate and provide cost savings.
More effective means of medicines reconciliation in 
hospital and primary care—for example, through the 
availability of a summary care record—may allow for 
more of clinicians’ time to be focused on assessment 
of the appropriateness of drugs.56 Similarly, 
implementing a standardised electronic format for 
discharge summaries could improve their quality and 
reduce discrepancies arising from transitions between 
hospital and primary care.57 As well as reducing 
deficits in communication, a robust electronic record 
system could also incorporate decision support to aid 
clinicians in reviewing prescriptions, which, combined 
with incentives and professional education, has been 
shown to effectively reduce high risk prescribing 
and associated adverse events.58 A large scale study 
of almost a million patients in UK general practice 
showed high variation between practices in the 
prevalence of such high risk prescribing,59 suggesting 
that practice level interventions to improve prescribing 
should be targeted. Variation among practices in the 
effect of hospital admission on appropriate prescribing 
also warrants examination to help to inform strategies 
to improve this.
Individual clinicians may consider several 
potential solutions. A recent systematic review 
identified incomplete clinical picture (information 
deficits due to poor communication among multiple 
prescribers and fragmentation at care interfaces) 
as a barrier to minimising inappropriate drugs by 
prescribers.60 Many of the common STOPP criteria 
in our study relate to inappropriate duration of use, 
so documenting and clearly communicating the 
intended duration of the prescription or a planned 
review date would ensure that other clinicians such as 
general practitioners have complete information for 
reviewing and stopping such prescriptions. Similarly, 
documentation of the indication for a drug will 
facilitate review of appropriateness and continued 
need.60 The indication and duration should also be 
discussed with patients, which would mean that 
they expect future review or stopping of drugs and 
thus reduce the ambivalence/resistance of patients 
to change as a barrier to appropriate prescribing.60 61 
Prescribers have also cited a lack of evidence and 
difficulty in assessing the benefits/harms of treatment 
Table 2 | Comparison of models adjusted for morbidity using Charlson comorbidity index (standard analysis) and RxRisk 
(sensitivity analysis)
Estimate No Hazard ratio (95% confidence interval)* Odds ratio (95% credible interval)*
Admitted to hospital (relative to not admitted)
Adjusted for Charlson comorbidity index 28 831 1.24 (1.20 to 1.27) 1.49 (1.42 to 1.59)
Adjusted for RxRisk 38 169 1.25 (1.22 to 1.29) 1.55 (1.47 to 1.64)
After admission (relative to before admission)
Adjusted for Charlson comorbidity index 9549 - 1.72 (1.63 to 1.84)
Adjusted for RxRisk 11 277 - 1.71 (1.63 to 1.81)
*Additionally adjusted for age, sex, number of prescriptions items, and health cover type.
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as a barrier.60 Several evidence based guidelines have 
recently been developed to support decisions on 
deprescribing specific drugs, including proton pump 
inhibitors, benzodiazepines, and Z drugs, which were 
among the most prevalent problems identified in 
our study.62 63 Deprescribing algorithms and patient 
information leaflets and decision aids as companions 
to these guidelines are also available from www.
deprescribing.org.
We cannot determine whether the observed increase 
in potentially inappropriate prescribing is a consequence 
of illness that prompted hospital admission, and 
the increased complexity this may bring, or whether 
potentially inappropriate prescribing is a consequence 
of further medical intervention during the hospital stay. 
Future research should identify the mechanisms by 
which hospital admission is associated with potentially 
inappropriate prescribing, including detailed review 
of patients’ clinical records to explore how potentially 
inappropriate prescribing may have been contributory 
or causal in hospital admissions and to understand the 
clinical decisions (in both primary and secondary care) 
that resulted in potentially inappropriate prescribing 
among patients after discharge from hospital. Research 
should also evaluate how to overcome these problems to 
enhance appropriateness of prescribing for older patients 
after discharge. This may include better continuity of 
information through improved health information and 
communication technology infrastructure, as well as 
formal transitional care programmes.54 64 In addition, 
hospital based interventions to enhance appropriateness 
of prescribing for older patients should be evaluated, 
such as reviews using prescribing criteria like STOPP or 
alignment of clinical pharmacists with medical teams to 
provide integrated medicines management.65 66
Conclusions
This study shows that potentially inappropriate 
prescribing is becoming increasingly prevalent among 
community dwelling older people according to the 
most recent STOPP criteria. Furthermore, hospital 
admission is independently associated with an 
increased risk of potentially inappropriate prescribing 
after discharge back to primary care. Identifying 
optimal management strategies for older people is 
vital to ensure that the risk of inappropriate drugs is 
minimised after transitions of care.
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